HopeStage
Back to all studies
CompletedNCT07099235

Chart Review of Patients Undergoing Ketamine Treatments for Depression

Observational studyAges 18+Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
MississaugaSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: April 1, 2022
Recruitment status
Completed
Enrollment listed in the registry
250
Sponsor
Sunnybrook Health Sciences Centre
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Drug
Locations
Canada
Age range
Over 18 Years
Official registry ID
NCT07099235
Official title
Show the full official title

Retrospective Chart Review of Patients Undergoing Intravenous Ketamine Treatments for Treatment-resistant Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Mississauga

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sunnybrook Health Sciences Centre.

Did this study involve medication?

Yes. The study involved medication, including ketamine hydrochloride.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies